Cargando…

Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation

Detalles Bibliográficos
Autores principales: Han, Jin-Hwan, Cai, Mingmei, Grein, Jeffery, Perera, Samanthi, Wang, Hongmei, Bigler, Mike, Ueda, Roenna, Rosahl, Thomas W., Pinheiro, Elaine, LaFace, Drake, Seghezzi, Wolfgang, Williams, Sybil M. Genther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709894/
https://www.ncbi.nlm.nih.gov/pubmed/33329611
http://dx.doi.org/10.3389/fimmu.2020.615755
_version_ 1783617843625984000
author Han, Jin-Hwan
Cai, Mingmei
Grein, Jeffery
Perera, Samanthi
Wang, Hongmei
Bigler, Mike
Ueda, Roenna
Rosahl, Thomas W.
Pinheiro, Elaine
LaFace, Drake
Seghezzi, Wolfgang
Williams, Sybil M. Genther
author_facet Han, Jin-Hwan
Cai, Mingmei
Grein, Jeffery
Perera, Samanthi
Wang, Hongmei
Bigler, Mike
Ueda, Roenna
Rosahl, Thomas W.
Pinheiro, Elaine
LaFace, Drake
Seghezzi, Wolfgang
Williams, Sybil M. Genther
author_sort Han, Jin-Hwan
collection PubMed
description
format Online
Article
Text
id pubmed-7709894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77098942020-12-15 Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation Han, Jin-Hwan Cai, Mingmei Grein, Jeffery Perera, Samanthi Wang, Hongmei Bigler, Mike Ueda, Roenna Rosahl, Thomas W. Pinheiro, Elaine LaFace, Drake Seghezzi, Wolfgang Williams, Sybil M. Genther Front Immunol Immunology Frontiers Media S.A. 2020-11-18 /pmc/articles/PMC7709894/ /pubmed/33329611 http://dx.doi.org/10.3389/fimmu.2020.615755 Text en Copyright © 2020 Han, Cai, Grein, Perera, Wang, Bigler, Ueda, Rosahl, Pinheiro, LaFace, Seghezzi and Williams http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Han, Jin-Hwan
Cai, Mingmei
Grein, Jeffery
Perera, Samanthi
Wang, Hongmei
Bigler, Mike
Ueda, Roenna
Rosahl, Thomas W.
Pinheiro, Elaine
LaFace, Drake
Seghezzi, Wolfgang
Williams, Sybil M. Genther
Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title_full Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title_fullStr Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title_full_unstemmed Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title_short Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation
title_sort corrigendum: effective anti-tumor response by tigit blockade associated with fcγr engagement and myeloid cell activation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709894/
https://www.ncbi.nlm.nih.gov/pubmed/33329611
http://dx.doi.org/10.3389/fimmu.2020.615755
work_keys_str_mv AT hanjinhwan corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT caimingmei corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT greinjeffery corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT pererasamanthi corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT wanghongmei corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT biglermike corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT uedaroenna corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT rosahlthomasw corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT pinheiroelaine corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT lafacedrake corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT seghezziwolfgang corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation
AT williamssybilmgenther corrigendumeffectiveantitumorresponsebytigitblockadeassociatedwithfcgrengagementandmyeloidcellactivation